Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-20-001609
Filing Date
2020-12-22
Accepted
2020-12-22 19:40:19
Documents
1
Period of Report
2020-12-18

Document Format Files

Seq Description Document Type Size
1 e620163_4-payne.html 4  
1 e620163_4-payne.xml 4 4006
  Complete submission text file 0001193805-20-001609.txt   5389
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address
Payne Joseph E (Reporting) CIK: 0001727315 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38942 | Film No.: 201409453

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Issuer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations